BEGIN:VCALENDAR
PRODID:-//Event Calendar 2.0//iCal4j 2.0//EN
CALSCALE:GREGORIAN
VERSION:2.0
BEGIN:VEVENT
DTSTAMP:20260905T173105Z
DTSTART:20250909T170000
DTEND:20250909T180000
SUMMARY:Dr. Thomas Mager: Improved Channelrhodopsins for Future Optogenetic Therapies
TZID:Europe/Berlin
UID:event-12484992@events.goettingen-campus.de
LOCATION:Max-Planck-Institut für Multidisziplinäre Naturwissenschaften (MPI-NAT\, City-Campus) - Lecture Hall
CONTACT:Dr. Heike Contrad\, heike.conrad@med.uni-goettingen.de\, 0551 3961305
CATEGORIES:research
DESCRIPTION:The Lecture Series of the Hertha Sponer College\, which has been established at the Multiscale Bioimaging Cluster of Excellence (MBExC)\, is addressed to interested students\, PhD candidates\, postdocs\, and PIs. The overall idea is to fundamentally explain research by providing an overview about the general aims of the six MBExC Research Alliances with special focus on the specific techniques that are developed and applied.\n\nTitle: Hertha Sponer College Lecture Series: Improved Channelrhodopsins for Future Optogenetic Therapies\nSpeaker: Dr. Thomas Mager\nOrganizer: Cluster of Excellence Multiscale Bioimaging (MBExC)\, Zentren und Netzwerke\nHost: Hertha Sponer College\nContact: Dr. Heike Contrad\, heike.conrad@med.uni-goettingen.de\, 0551 3961305\n
URL:https://events.goettingen-campus.de/event?eventId=12484992
END:VEVENT
END:VCALENDAR